MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Cardiovascular, Cardiac & Cardiology Companies _ Congestive Heart Failure (CHF)
VisCardia, Inc.
Organization & Developments: VisCardia
Parents
VisCardia, Inc.
Children
*Device based on electronic sensor and electrode system that delivers electrical stimulation for mediating thoracic pressure augmentation to improve cardiac filling and relieve symptoms of hemodynamic insufficiency.
*Implantable to treat thoracic cardiac diseases
*Synchronized Diaphragmatic StimulationTM therapy (SDS® therapy)
2020: VisCardia Announces Its Novel Heart Failure Therapy Receives Breakthrough Device Designation From the FDA
2025: VisCardia Wins Inaugural MedTech Innovator Impact Award at 32nd Annual Medical Device & Digital Health Conference
Jumps
Finance & Acquisition: VisCardia
Key People: VisCardia